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Abstract: 1,3-Disubstituted-4-thioxoimidazolidin-2-one derivatives with various substituents at N1 and N3 were synthesized with high yields and 
excellent purity by the reaction of various N-arylcyanothioformamide derivatives with isocyanate derivatives. The activity of these products as 
antibacterial and antifungal agents was studied to through some light on structural activity relationship. Some of synthesized compounds 
showed significant antibacterial and antifungal activities. Most of the imidazole derivatives possess significant antifungal activity aginst S. 
cerevisiae (MIC 1–10 µg mL–1). As comparision with ketoconazole, most of the imidazole derivatives showed activity ranging from 50 % less activity 
to fourfold activity. 
 





MIDAZOLE derivatives are keys compounds in many 
bioactive compounds of natural and synthetic origins. 
Nitroimidazoles are a well-known family of antibacterial 
and antiprozoal drugs, including anti-trypanosomal drugs 
or compounds with known anti-trypanosomal activity.[1] 
For more than 50 years, metronidazole was the first drug 
introduced as antiparasit agent and it was the best-known 
drug in this class.[2] Imidazolidineiminothione derivatives 
and their related heterocycles exhibit interesting 
pharmacological effects such as antibacterial, antifungal 
antiviral and antitumor agents.[3–7] 
 Bacterial infection and fungal infection are among 
the widespread and serious diseases. To overcome these 
serious diseases, the discovery of new types of antimicro-
bial agents is a very important task. Recently, the research 
has been focused on the development of new antimicrobial 
agents, which may act through novel targets and structure 
design.[8–10] 
 In light of these facts, the present study was 
designed to synthesize new imidazole derivatives and eval-
uate their antimicrobial activity. As a trial to obtain novel 
class of antibacterial and antifungal agents, various groups 
were introduced into the target compounds. 
 
EXPERIMENTAL 
IR spectra were recorded (KBr) on a Perkin Elmer 1650 
spectrophotometer. 1H NMR and 13C NMR spectra were 
recorded on Avance II Bruker FT NMR spectrometer 400 
(400 MHz) using CDCl3 as solvents and TMS as an internal 
standard. CFCl3 was used as an internal standard for all 19F 
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ppm units. NMR spectra were recorded at Department of 
Chemistry, Faculty of Science, Taibah University, Almadinah 
lmunawarrah, Saudi Arabia Mass spectrawere recorded on 
Shimadzu GC-MS QP 100 EX (70 eV) at the Micro Analytical 
Center at Cairo University. Melting points were obtained on 
a Fishere Johns melting points apparatus and are 
uncorrected. 
General Procedure for the Synthesis of 
Imidazolidineiminothione Derivatives 
2a–h 
Solution of the cyanothioformanilide derivative ((3,5-
dichlorophenyl)carbamothioyl cyanide) (0.01 mol) and the 
corresponding isocyanate derivatives (0.01 mol) in dry 
ether (30 mL) was treated with three drops of 
triethylamine. The reaction mixture was stirred for 15 min. 
The obtained product was filtered off, washed with ether, 
air-dried and recrystallized from chloroform / n-hexane to 




Yield 88 %; mp 160–162 °C; IR: ν / cm–1: 3221 (NH), 1756 
(C=O), 1645 (C=N), 1126 (C=S); 1H NMR (d1-TFA/CDCl3; 1/1, 
400 MHz): δ / ppm = 7.41–7.48 (m, 2H, Ar–H), 7.49–7.52 
(m, 2H, Ar-H), 7.62–7.67 (m, 3H, Ar–H), 7.71 (t, 1H, J = 1.8 
Hz, Ar–H), 9.53 (br, 1H, NH); 13C NMR (d1-TFA /CDCl3; 1/1, 
100 MHz): 125.7 (CH), 126.8 (2CH), 129.3 (C-N), 130.6 
(2CH), 131.0 (C–N), 131.6 (2CH), 133.2 (CH), 138.1 (2C–Cl), 
150.2 (C=N), 152.0 (C=O), 176.3 (C=S); MS (m / z: %): 350 (M+, 
20.1), 135 (100); Anal. Calcd for C15H9Cl2N3OS (350.22): C, 




Yield 84 %; mp 136–138 °C; IR: ν / cm–1: 3242 (NH), 1765 
(C=O), 1644 (C=N), 1109 (C=S); 1H NMR (d1-TFA /CDCl3; 1/1, 
400 MHz): δ / ppm = 7.25–7.36 (m, 2H, Ar–H) 7.43–7.48 (m, 
2H, Ar–H), 7.49 (d, 2H, J = 1.8 Hz, Ar–H), 7.71 (t, 1H, J = 1.8 
Hz, Ar–H), 9.51 (br, 1H, NH); 13C NMR (d1-TFA /CDCl3; 1/1, 
100 MHz): 117.7 (d, J = 23.5 Hz, CH); 125.7 (CH), 126.8 (d, J = 
3.2 Hz, C-N), 129.1 (d, J = 9.6 Hz, CH), 129.2 (C–N), 133.2 
(2CH), 138.0 (2C–Cl), 150.3 (C=N), 152.0 (C=O), 164.3 (d, J = 
253.4 Hz, C-F), 176.4 (C=S); 19F (DMSO, 376.5 MHz): –108.5; 
Anal. Calcd for C15H8Cl2FN3OS (368.21): C, 48.93; H, 2.19; N, 




Yield 89 %; mp 214–215 °C; IR: ν / cm–1: 3234 (NH), 1766 
(C=O), 1654 (C=N), 1102 (C=S); 1H NMR (d1-TFA /CDCl3; 1/1, 
400 MHz): δ / ppm = 7.40 (d, 2H, J = 8.8 Hz, Ar–H), 7.46 (d, 
2H, J = 1.8 Hz, Ar–H), 7.62 (d, 2H, J = 8.8 Hz, Ar–H), 7.69 (t, 
1H, J = 1.8 Hz, Ar–H), 9.52 (br, 1H, NH); 13C NMR (d1-TFA 
/CDCl3; 1/1, 100 MHz): 125.5 (CH), 128.0 (CH), 129.0 (C–N), 
129.1 (C–N), 130.7 (CH), 133.0 (CH), 137.7 (C–Cl), 137.8 (C–
Cl), 150.0 (C=N), 151.4 (C=O), 175.8 (C=S); MS (m / z: %): 
385 (M+, 25.9), 169 (100); Anal. Calcd for C15H8Cl3N3OS 
(384.67): C, 46.84; H, 2.10; N, 10.92; Found: C, 46.94; H, 




Yield 84 %; mp 200–202 °C; IR: ν / cm–1: 3240 (NH), 1777 
(C=O), 1660 (C=N), 1126 (C=S); 1H NMR (d1-TFA /CDCl3; 1/1, 
400 MHz): δ / ppm = 7.35 (d, 2H, J = 8.8 Hz, Ar–H), 7.49 (d, 
2H, J = 1.7 Hz, Ar–H), 7.71 (t, 1H, J = 1.7 Hz, Ar–H), 7.79 (d, 
2H, J = 8.8 Hz, Ar–H), 9.49 (br, 1H, NH); 13C NMR (d1-TFA 
/CDCl3; 1/1, 100 MHz): 125.7 (CH), 126.0 (C–Br), 128.3 (CH), 
129.2 (C–N), 129.8 (C–N), 133.2 (CH), 133.9 (CH), 138.0 (C–
Cl), 150.3 (C=N), 151.7 (C=O), 176.0 (C=S); MS (m / z: %): 
429 (M+, 19.1), 215 (100); Anal. Calcd for C15H8BrCl2N3OS 





Yield 86 %; mp 189–190 °C; IR: ν / cm–1: 3227 (NH), 1771 
(C=O), 1659 (C=N), 1120 (C=S); 1H NMR (d1-TFA /CDCl3; 1/1, 
400 MHz): δ / ppm = 7.20 (d, 2H, J = 8.0 Hz, Ar–H), 7.43–
7.52 (m, 3H, Ar–H), 8.02 (d, 2H, J = 8.0 Hz, Ar–H), 9.50 (br, 
1H, NH); 13C NMR (d1-TFA /CDCl3; 1/1, 100 MHz): 97.4 C–I), 
125.8 (CH), 128.3 (CH), 129.2 C–N), 130.5 C–N), 133.3 (CH), 
138.0 C–Cl), 140.0 (CH), 150.3 (C=N), 151.7 (C=O), 176.0 
(C=S); MS (m / z: %): 474 (M+, 39.4), 260 (100); Anal. Calcd 
for C15H8Cl2IN3OS (476.12): C, 37.84; H, 1.69; N, 8.83; 




Yield 88 %; mp 207–208 °C; IR: ν / cm–1: 3240 (NH), 1771 
(C=O), 1667 (C=N), 1121 (C=S); 1H NMR (d1-TFA /CDCl3; 1/1, 
400 MHz): δ / ppm = 2.48 (s, 3H, CH3), 7.32 (d, 2H, J = 8.3 
Hz, Ar–H), 7.44 (d, 2H, J = 8.3 Hz, Ar–H), 7.50 (d, 2H, J = 1.8 
Hz, Ar–H), 7.70 (t, 1H, J = 1.8 Hz, Ar–H), 9.51 (br, 1H, NH); 
13C NMR (d1-TFA /CDCl3; 1/1, 100 MHz): 20.9 (CH3), 125.7 
(CH), 126.5 (CH), 128.2 (C–N), 129.3 (C–N), 131.1 (CH), 
133.2 (CH), 138.0 (C–Me), 142.6 (C–Cl), 150.2 (C=N), 152.4 
(C=O), 176.4 (C=S); MS (m / z: %): 364 (M+, 24.3), 91(100); 
Anal. Calcd for C16H11Cl2N3OS (364.25): C, 52.76; H, 3.04; N, 




Yield 79 %; mp 154–156 °C; IR: ν / cm–1: 3244 (NH), 1772 
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400 MHz): δ / ppm = 3.87 (s, 3H, OCH3), 3.98 (s, 3H, OCH3), 
6.73–6.79 (m, 1H, Ar–H), 7.25–7.32 (m, 2H, Ar–H), 7.49 (d, 
2H, J = 1.8 Hz, Ar–H), 7.69 (t, 1H, J = 1.8 Hz, Ar–H), 9.49 (br, 
1H, NH); 13C NMR (d1-TFA /CDCl3; 1/1, 100 MHz): 56.1 
(2OCH3), 100.6 (CH), 125.7 (CH), 129.3 (C–N), 129.6 (CH), 
129.7 (CH), 133.1 (CH), 138.0 (C–Cl), 150.2 (C=N), 152.0 
(C=O), 155.9 (C–O), 156.0 (C–O), 176.0 (C=S); MS (m / z: %): 
410 (M+, 31.5), 189 (100); Anal. Calcd for C17H13Cl2N3O3S 
(410.27): C, 49.77; H, 3.19; N, 10.24; Found: C, 49.83; H, 




Yield 81 %; mp 178–180 °C; IR: ν / cm–1: 3240 (NH), 1777 
(C=O), 1660 (C=N), 1126 (C=S); 1H NMR (d1-TFA /CDCl3; 1/1, 
400 MHz): δ / ppm = 1.51 (t, 3H, J = 7.0 Hz, CH2CH3), 4.26 
(q, 2H, J = 7.0 Hz, CH2CH3), 7.19 (d, 2H, J = 9.0 Hz, Ar–H), 
7.40 (d, 2H, J = 9.0 Hz, Ar–H), 7.50 (d, 2H, J = 1.7 Hz, Ar–H), 
7.71 (t, 1H, J = 1.7 Hz, Ar–H), 9.56 (br, 1H, NH); 13C NMR (d1-
TFA /CDCl3; 1/1, 100 MHz): 14.1 (CH3), 65.6 (CH2), 116.7 
(CH), 124.0 (C–N), 125.7 (C–H), 128.4 (CH), 129.3 (C–N), 
138.1 (C–Cl), 133.2 (CH), 150.3 (C=N), 152.4 (C=O), 160.4 
(C–O), 176.5 (C=S); MS (m / z: %): 394 (M+, 22.7), 151 (100); 
Anal. Calcd for C17H13Cl2N3O2S (394.28): C, 51.79; H, 3.32; N, 
10.66; Found: C, 51.74; H, 3.29; N, 10.73. 
General Procedure for the Synthesis of 
5-Imino-4-thioxoimidazolidin-2-one 
Derivatives 4a,b 
A solution of the cyanothioformanilide derivatives (0.01 mol) 
and 1,3-dichloro-5-isocyanatobenzene (0.01 mol) in dry 
ether (30 mL) was treated with three drops of triethylamine. 
The reaction mixture was stirred for 15 min. The obtained 
product was filtered off, washed with ether, air-dried and 
recrystallized from chloroform / n-hexane to give imidazo-




Yield 85 %; mp 194–196 °C; IR (KBr): ν / cm–1 = 3420 (NH), 
1784 (C=O), 1667 (C=N), 1105 (C=S); 1H NMR (CDCl3, 400 
MHz): δ / ppm = 7.38–7.43 (m, 1H, Ar–H), 7.59–7.46 (m, 7H, 
Ar–H), 9.50 (s, 1H, NH); 13C NMR (CDCl3, 100 MHz): δ / ppm 
= 127.1 (CH); 127.9 (C), 128.9 (CH), 129.5 (CH), 129.8 (CH), 
131.7 (CH), 132.6 (C), 135.5 (C), 152.3 (C=O and C=N), 181.3 
(C=S), MS (m / z: %): 350 (M+, 3.4), 135 (100); Anal. Calcd 
for C15H9Cl2N3OS (350.22): C, 51.44; H, 2.59; N, 12.00; 




Yield 83 %; mp 207–209 °C; IR: ν / cm–1: 3231 (NH), 1772 
(C=O), 1644 (C=N), 1125 (C=S); 1H NMR (d1-TFA /CDCl3; 1/1, 
400 MHz): δ / ppm = 7.42 (d, 2H, J = 8.8 Hz, Ar–H), 7.67 (m, 
3H, Ar–H), 7.82 (d, 2H, J = 8.8 Hz, Ar–H), 9.52 (br, 1H, NH); 
13C NMR (d1-TFA /CDCl3; 1/1, 100 MHz): 123.5 (C-Br); 126.2 
(C–N), 128.5 (C–H), 129.8 (C–N), 130.3 (CH), 134.1 (CH), 
135.0 (C–Cl), 135.2 (CH), 149.7 (C=N), 150.5 (C=O), 175.1 
(C=S); MS (m / z: %): 429 (M+, 10.8), 124 (100); Anal. Calcd 
for C15H8BrCl2N3OS (429.12): C, 41.98; H, 1.88; N, 9.79; 
Found: C, 42.11; H, 1.91; N, 9.84. 
General Procedure for the Synthesis of 
5-Imino-4-thioxoimidazolidin-2-one 
Derivatives 6a–c 
A solution of the cyanothioformanilide derivatives (0.01 mol) 
and (isocyanatomethyl)benzene (0.01 mol) in dry ether (30 
mL) was treated with three drops of triethylamine. The 
reaction mixture was stirred for 15 min. The obtained 
product was filtered off, washed with ether, air-dried and 
recrystallized from chloroform / n-hexane to give imidazoli-




Yield 80 %; mp 123-125 °C; IR (KBr): ν / cm–1 = 3410 (NH), 
1780 (C=O), 1668 (C=N), 1082 (C=S); 1H NMR (CDCl3, 400 
MHz): δ / ppm = 2.40 (s, 3H, CH3) , 4.98 (s, 2H, CH2), 7.20–
7.38 (m, 7H, Ar–H), 7.48–7.54 (m, 2H, Ar–H), 9.36 (br, 1H, 
NH); 13C NMR (CDCl3, 100 MHz): 21.3 (CH3), 44.3 (CH2), 
126.7 (CH), 128.2 (CH), 128.7 (CH), 129.0 (CH), 130.0 (CH), 
130.1 (C), 135.3 (C), 139.7 (C), 153.7 (C=O), 154.7 (C=N), 
182.0 (C=S); MS (m / z: %): 309 (M+, 20.8), 91 (100): Anal. 
Calcd for C17H15N3OS (309.39): C, 66.00; H, 4.89; N, 13.58; 




Yield 89 %; mp 133–135 °C; IR (KBr): ν / cm–1 = 3428 (NH), 
1775 (C=O), 1665 (C=N), 1254 (C–O), 1146 (C–O), 1086 
(C=S); 1H NMR (CDCl3, 400 MHz) δ / ppm = 3.84 (s, 3H, 
OCH3), 4.98 (s, 2H, CH2), 7.00 (d, 2H, J = 9.1 Hz, Ar–H), 7.27–
7.39 (m, 5H, Ar–H), 7.49–7.54 (m, 2H, Ar–H), 9.36 (br, 1H, 
NH); 13C NMR (CDCl3, 100 MHz): 44.4 (CH2)  55.5 (CH3), 
114.6 (CH), 125.3 (C), 128.2 (CH), 128.3 (CH), 128.7 (CH), 
129.0 (CH), 135.4 (C), 153.7 (C=O), 154.9 (C=N), 160.1 (C–
O), 182.2 (C=S); MS (m / z: %): 325 (M+, 52.1), 51(100); Anal. 
Calcd for C17H15N3O2S (325.38): C, 62.75; H, 4.65; N, 12.91; 




Yield 83 %; mp 131–133 °C; IR (KBr) 3435 (NH), 1775 (C=O), 
1667 (C=N), 1250 (C–O), 1138 (C–O), 1084 (C=S); 1H NMR 
(CDCl3, 400 MHz): δ / ppm =  1.43 (t, 3H, J = 7.0 Hz, CH2CH3), 
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2H, J = 9.1 Hz, Ar–H), 7.24–7.39 (m, 5H, Ar–H), 7.49–7.54 
(m, 2H, Ar–H), 9.35 (br, 1H, NH); 13C NMR (CDCl3, 100 MHz): 
14.7 (CH3), 44.4 (CH2), 63.8 (CH2), 115.1 (CH), 125.0 (C), 
128.1 (CH), 128.2 (CH), 128.7 (CH), 129.0 (CH), 135.4 (C), 
153.7 (C=O), 154.9 (C=N), 159.5 (C-O), 182.2 (C=S); MS (m / 
z: %): 339 (M+, 29.4), 91 (100); Anal. Calcd for C18H17N3O2S 
(339.41): C, 63.70; H, 5.05; N, 12.38; Found: C, 63.62; H, 
5.01; N, 12.42. 
Synthesis of Imidazolidin-2,5-diones 7a–c 
Each one of imidazolidineiminothione derivatives 6a–c 
(0.01 mol) was dissolved in boiling ethanol (20 mL) and 
treated with dil. HCl (1 : 1 molar ratio). The obtained products 
were filtered off, washed with cold water, air-dried, and 
recrystallized from chloroform / n-hexane to give the 




Yield 73 %; mp 105–106 °C; IR (KBr): ν / cm–1 = 1740 (C=O), 
1090 (C=S); 1H NMR (CDCl3, 400 MHz): δ / ppm = 2.41 (s, 
3H, CH3), 4.89 (s, 2H, CH2), 7.21–7.25 (m, 2H, Ar–H), 7.28–
7.33 (m, 2H, Ar–H), 7.34-7.40 (m, 3H, Ar–H), 7.46–7.52 (m, 
2H, Ar–H); 13C NMR (CDCl3, 100 MHz): 21.3 (CH3),  43.8 
(CH2), 126.8 (CH), 128.6 (CH), 129.0 (CH), 129.2 (CH), 129.4 
(C), 130.1 (CH), 140.0 (C), 134.5 (C), 153.6 (C=O), 154.1 
(C=O), 183.1 (C=S); MS (m / z: %): 310 (M+, 28.1), 91(100); 
Anal. Calcd for C17H14N2O2S (310.37): C, 65.79; H, 4.55; N, 




Yield 80 %; mp 104–105 °C; IR (KBr): ν / cm–1 = 1738 (C=O), 
1252 (C–O), 1167 (C–O), 1094 (C=S); 1H NMR (CDCl3, 400 
MHz): δ / ppm = 3.84 (s, 3H, OCH3); 4.88 (s, 2H, CH2), 7.00 
(d, 2H, J = 9.1 Hz, Ar–H), 7.26 (d, 2H, J = 9.1 Hz, Ar–H), 7.32–
7.40 (m, 3H, Ar–H), 7.46-7.51 (m, 2H, Ar–H); 13C NMR 
(CDCl3, 100 MHz): 43.8 (CH2); 55.5 (CH3), 114.7 (CH), 124.5 
(C), 128.3 (CH), 128.6 (CH), 129.0 (CH), 129.2 (CH), 134.5 
(C), 153.7 (C=O), 154.2 (C=O), 160.2 (C-O), 183.2 (C=S), MS 
(m / z: %): 326 (M+, 45), 91(100); Anal. Calcd for 
C17H14N2O3S (326.37): C, 62.56; H, 4.32; N, 8.58; Found: C, 




Yield 88 %; mp 120–121 °C; IR (KBr): ν / cm–1 = 1744 (C=O), 
1250 (C–O), 1169 (C–O), 1088 (C=S); 1H NMR (CDCl3, 400 
MHz): δ / ppm = 1.43 (t, 3H, J = 7.0 Hz,), 4.06 (q, J = 7.0 Hz, 
2H), 4.88 (s, 2H), 6.98 (d, J = 9.0 Hz, 2H), 7.25 (d, J = 9.0 Hz, 
2H), 7.31–7.40 (m, 3H, Ar–H), 7.45–7.51 (m, 2H, Ar–H); 13C 
NMR (CDCl3, 100 MHz): 14.7 (CH3), 43.8 (CH2), 63.8 (CH2), 
115.2 (CH), 124.3 (C), 128.2 (CH), 128.6 (CH), 129.2 (CH), 
130.0 (CH), 134.5 (C), 153.7 (C=O), 154.3 (C=O), 159.6 (C–
O), 183.2 (C=S); MS (m / z: %): 340 (M+, 17.8), 91 (100); Anal. 
Calcd for C18H16N2O3S (340.40): C, 63.51; H, 4.74; N, 8.23; 
Found: C, 63.47; H, 4.77; N, 8.34 
Antimicrobial Screening 
MICs were assessed by serial broth dilution method.[12] The 
freshly prepard inocula were incubated for 24 h at 37 °C in 
NB for bacteria and 48 h at 30 °C in Sabouraud dextrose 
broth for fungi. The chemical compounds were first dis-
solved in DMSO and then different concentrations of them 
were prepared by diluting the samples in NB and 
Sabouraud dextrose broth for bacteria and fungi, respec-
tively to reach the final concentration of 1 to 100 µg mL–1. 
Each one mL from the above concentrations received  
0.1 mL of the inoculum to reach 106 CFU mL–1 for bacteria 
and fungi. Triplicate tests were performed and the average 
was taken as the final reading comparing to negative and 
positive controls. 
 
RESULTS AND DISCUSSION 
Chemistry 
Cyanothioformamide derivative 1 was prepared by reac-
tion 3,5-dichlorophenylisothiocyanate with potassium cya-
nide according to literature procedure.[5] The tautomeric 
nature of the N-arylcyanothioformamide reflects their 
nucleophilic character in which they may react via the 
nitrogen or sulfur atom leading to different ring closing re-
actions. Reaction of N-arylcyanothioformamide derivative 
1 with various isocyanate derivatives in ether, followed by 
addition of a few drops of triethylamine as catalyst afforded 
imidazolidineiminothione derivatives 2a–h (Scheme 1). 
Their IR, NMR (1H and 13C) and mass spectra indicated that 
5-imino-4-thioxo-2-imidazolidinone derivatives 2a–h were 
furnished as the sole products, indicating that the ring 
closing reaction proceeds via a single path which involves 
attack via the nitrogen atom. 
 It has been reported that moving side chain around 
the the main scaffold to the other position can result in 
retention of biological activities and providing new oppor-
tunities for the design of bioactive compounds.[11] These 
observations gave us an additional motivation to combina-
tion of the 3,5-dichlorophenyl moiety with imidazole scaf-
fold at N-(1) of the imidazole. Therefore, treating an 
ethereal solution of N-arylcyanothioformamides 3a,b with 
3,5-dichlorophenylisocyanate, followed by addition of a 
few drops of triethylamine afforded imidazolidineiminothi-
one derivatives 4a,b. 
 Moreover, our investigation was extended to include 
the behavior of benzylisothiocyanate toward different N-
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mamides 5a–c were let to react with benzylisothiocyanate in 
ether in precence of a few drops of triethylamine, imid-
azolidineiminothione derivatives 6a–c were afford in good 
yeilds. The structure of compounds 6a–c was inferred from 
their correct elemental analyses and spectral data. To obtain 
another type of imidazole, hydrolysis of 6a–c with dilute HCl 
was carredout in boiling ethanol and the corresponding 
dione derivatives 7a–c were abtianed (Scheme 3). 
Biological Activity 
The aim of the present investigation is to synthesize series 
of imidazolidineiminothiones was bearing various sub-
stituent at N-(1) and others at N-(3). The antibacterial and 
antifungal activities of these derivatives were measured. 
The effect of each substituent at N-(1) and at N-(3) on these 
activities was studied and make a comparative study 
between them to deduce a structure activity relationship 
was made. A series of imidazolidineiminothione 2a–h 
containing 3,5-dichlorophenyl moiety at N-(1) and various 
aryl at N-(3) was synthesized. The effect of each substituent 
on N-(3) of the imidazolidine ring on the activities of the 
imidazoslidines 2a–h was studied. Thus, changing the 
substituent on N-(3) from phenyl to 4-fluorophenyl, 4-
chlorophenyl, 4-bromophenyl, 4-iodophenyl, 4-tolyl, 2,4-
dimethoxyphenyl and 4-ethoxyphenyl (2a, 2b, 2c, 2d, 2e, 
2f, 2g and 2h) was carried out to show the difference 
between F, Cl, Br, I, CH3, OCH3 and OC2H5 on the effect of 
the biological activities. Inverse the substituent at N-(1) and 
N-(3) was carried out where 3,5-dichlorophenyl moiety was 
attached to N-(3) instead if N-(1), and phenyl (4a) and 4-
bromophenyl (4b) was attached to N-(1) instead of  N-(3), 
in order to study the difference of biological activity 
between 2a and 4a, 2d and 4b. Another imidazolidineimi-
nothiones 6a–c which contain benzyl moiety at N-(1) and 
various moieties at N-(3) were synthesized. Changing the 
substituent on N-(3) from p-tolyl, p-anizyl and p-ethoxy-
phenyl (6a, 6b and 6c) was carried out. Moreover, the imine 
functional group in 6a–c was changed to carbonyl 
functional group in 7a–c while the substituent at N-(1) and 
N-(3) is not changed. 
Antibacterial and Antifungal Activities 
The newly synthesized target compounds were evaluated 
in vitro for their expected antimicrobial activity. Nine test 
organisms representing three different microbial groups 
were used: three Gram-positive bacteria, Bacillus subtilis 
ATCC 6633, B. cereus ATCC6629 and Staphylococcus aureus 
ATCC 29213; four Gram-negative bacteria, Klebseilla pe-
neumoniae ATCC 13883, Escherichia coli ATCC 25922, Pro-
teous vulgaris and salmonella typhimurium ATCC14028; 
fungi, Saccharomyces cerevisiae (local isolate) and Candida 
albicans ATCC10231. Ciprofloxacin and ketoconazole were 
used as standard references for antibacterial and antifungal 
activity, respectively. The minimal inhibitory concentrations 
(MICs) for the synthesized compounds were assessed by 
serial broth dilution method[12] and the MIC results (µg mL–1) 
were presented in Table 1. 
 Generaly, the mean values of the obtained MIC sug-
gest that most of the imidazole derivatives evaluated possess 
significant antibacterial activity against G +ve bacteria and no 
results against G -ve bactria. Also, most of the imidazole 
derivatives evaluated possess significant antifungal. A 
moderate difference in the antimicrobial activity is noted 
between the tested compounds. This suggested that, the 
main effect may be related to the presence of the imidazoli-
dinethione moiety. All of the imidazole derivatives possess 
significant antifungal aginst S. cerevisiae MIC (1–10 µg mL–1). 
As comparision with ketoconazole, the imidazole derivatives 
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Scheme 3. Synthesis of imidazolidineiminothione derivatives 
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disubstituted-4-thioxoimidazolidin-2-one derivatives with 
variable substituents at N-(1) and N-(3) have been 
described. Some compounds displayed antibacterial and 
antifungal activities. Generaly, the mean values of the 
obtained MIC suggest that some of the imidazole 
derivatives evaluated possess significant antibacterial 
activity against G +ve bacteria and no activity against G -ve 
bacteria. Also, some of the imidazole derivatives possess 
significant antifungal effect. A moderate difference in the 
antimicrobial activity is noted between the tested 
compounds. This suggested that, the main effect may be 
related to the presence of the imidazolidinethione moiety. 
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Table 1. Minimum inhibitory concentration (µg mL–1) of the synthesized compounds against the pathological organisms. 
Compd. 
no 
Gram +ve Gram –ve Fungi 
B. subtilis B. cereus S. aureus K. pneumonia E. coli P. vulgaris Salmonella S. cerevisiae C. albicans 
2a 30 > 500 50 > 500 > 500 > 500 > 500 4 20 
2b > 500 > 500 50 > 500 > 500 > 500 > 500 10 20 
2c 10 > 500 10 > 500 > 500 > 500 > 500 10 20 
2d 20 30 20 > 500 > 500 > 500 > 500 10 1 
2e 20 > 500 10 > 500 > 500 > 500 > 500 4 25 
2f 30 20 40 > 500 > 500 > 500 > 500 10 20 
2g 20 > 500 40 > 500 > 500 > 500 > 500 – 30 
2h > 500 20 > 500 > 500 > 500 > 500 > 500 10 20 
4a 20 30 40 > 500 > 500 > 500 > 500 4 30 
4b 25 30 40 > 500 > 500 > 500 > 500 4 30 
6a 30 > 500 40 > 500 > 500 > 500 > 500 10 30 
6b 20 > 500 50 > 500 > 500 > 500 > 500 1 20 
6c 20 30 40 > 500 > 500 > 500 > 500 10 20 
7a 2 30 50 > 500 > 500 > 500 > 500 10 30 
7b 20 30 50 > 500 > 500 > 500 > 500 1 30 
7c 20 20 50 > 500 > 500 > 500 > 500 4 30 
CFL 10 10 11 – – – – – – 
KET – – – – – – – 5 10 
 
